Abstract
Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.
Leibniz-HKI-Authors
Identifier
doi: 10.1016/j.ebiom.2021.103455
PMID: 34186490